Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide

Clinical Neurology and Neurosurgery

Volumn 112, Issue 8, 2010, Pages 662-667

  Yaman, Emel ^a   Buyukberber, Suleyman ^b   Benekli, Mustafa ^b   Oner, Yusuf ^b   Coskun, Ugur ^b   Akmansu, Muge ^b   Ozturk, Banu ^b   Kaya, Ali Osman ^b   Uncu, Dogan ^c   Yildiz, Ramazan ^b  

^a MERSIN STATE HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Early necrosis; MRI spectroscopy; Radiation; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN NECROSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RADIATION; RADIATION INJURY; RETROSPECTIVE STUDY; SPECTROSCOPY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NECROSIS; RADIATION INJURIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956182573     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2010.05.003     Document Type: Article

References (24)

1. A.A. Brandes, E. Franceschi, A. Tosoni, V. Blatt, A. Pession, and G. Tallini MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients J Clin Oncol 26 2008 2192 2197
2. D. Brandsma, L. Stalpers, W. Taal, P. Sminia, and M.J. van den Bent Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461
3. M.C. Chamberlain, M.J. Glantz, L. Chalmers, A. Van Horn, and A.E. Sloan Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma J Neurooncol 82 2007 81 83
4. C. Chaskis, B. Neyns, A. Michotte, A. Michotte, M. De Ridder, and H. Everaert Pseudoprogression after radiotherapy with concurrent temozolomide fpr high-grade glioma: clinical observations and working recommendations Surg Neurol 72 4 2009 423 428
5. D.J. Covarrubias, B.R. Rosen, and M.H. Lev Dynamic magnetic resonance perfusion imaging of brain tumors Oncologist 9 2004 528 537
6. M.C. De Wit, H.G. de Bruin, W. Eijkenboom, P.A. Sillevis Smitt, and M.J. van den Bent Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression Neurology 63 2004 535 537
7. P. Giglio, and M.R. Gilbert Cerebral radiation necrosis Neurologist 9 2003 180 188 [Review]
8. E.E. Graves, S.T. Nelson, D.B. Vigneron, L. Verhey, M. McDermott, and D. Larson Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery AJNR 22 2001 613 614
9. W. Hollingworth, L.S. Medina, R.E. Lenkinski, D.K. Shibata, B. Bernal, and D. Zurakowski A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors AJNR Am J Neuroradiol 27 7 2006 1404 1411
10. H.J. Jeon, D.S. Kong, K.B. Park, J.I. Lee, K. Park, and J.H. Kim Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastomas: single-center experience Clin Neurol Neurosurg 111 8 2009 679 682
11. P. Kleihues, and W.K. Cavenee Pathology and genetics of tumors of the nervous system World Health Organization Classification of the Tumors of the Nervous System, Editorial and Consensus Conference Working Group 2000 IARC Press Lyon, France
12. A.J. Kumar, N.E. Leeds, G.N. Fuller, P. Van Tassel, M.H. Maor, and R.E. Sawaya Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment Radiology 217 2000 377 384
13. C. Peca, R. Pacelli, A. Elefante, M.L. Del Basso De Caro, P. Vergara, and G. Mariniello Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis? Clin Neurol Neurosurg 111 4 2009 331 334
14. D.J. Rhee, D.S. Kong, W.S. Kim, K.B. Park, J.I. Lee, Y.L. Suh, and S.Y. Song Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas Clin Neurol Neurosurg 111 9 2009 748 751
15. J.P. Rock, D. Hearshen, L. Scarpace, D. Croteau, J. Gutierrez, and J.L. Fisher Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis Neurosurgery 51 2002 912 919
16. H.P. Schlemmer, P. Bachert, K.K. Herfarth, I. Zuna, J. Debus, and G. van Kaick Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy AJNR 22 2001 1316 1324
17. R. Stupp, W.P. Mason, M.J. Van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
18. J.S. Taylor, J.W. Langston, W.E. Reddick, P.B. Kingsley, R.J. Ogg, and M.H. Pui Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis Int J Radiat Oncol Biol Phys 36 1996 1251 1261
19. W. Taal, D. Brandsma, H.G. de Bruin, J.E. Bromberg, A.T. Swaak-Kragten, and P.A. Smitt Incidence of pseudoprogression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide Cancer 113 2008 405 410
20. P. Weybright, P.C. Sundgren, P. Maly, D.G. Hassan, B. Nan, and S. Rohrer Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy AJR Am J Roentgenol 185 2005 1471 1476
21. E. Yaman, S. Buyukberber, A. Uner, U. Coskun, M. Akmansu, and M. Benekli Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment Onkologie 31 2008 309 313
22. E. Yaman, S. Buyukberber, A. Uner, U. Coskun, D. Yamac, and B. Ozturk Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas Tumori 94 2008 674 680
23. Q.S. Zeng, C.F. Li, H. Liu, J.H. Zhen, and D.C. Feng Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging Int J Radiat Oncol Biol Phys 68 2007 151 158
24. Q.S. Zeng, C.F. Li, K. Zhang, H. Liu, X.S. Kang, and J.H. Zhen Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury Neurooncology 84 2007 63 69